The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
about
Mutation Profile of Well-Differentiated Thyroid Cancer in AsiansProgress in molecular-based management of differentiated thyroid cancerRAS mutations in thyroid cancerCIViC databaseNew insights in risk stratification of differentiated thyroid cancer.NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid.Molecular pathogenesis and mechanisms of thyroid cancerComparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer.Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancerComprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testingImmune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss.Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.Advances in thyroid cancer treatment: latest evidence and clinical potential.The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature.Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules.Molecular profiling of thyroid nodule fine-needle aspiration cytology.Mutation profile of differentiated thyroid tumours in an Australian urban population.Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report.Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.Paediatric follicular thyroid carcinoma - indolent cancer with low prevalence of RAS mutations and absence of PAX8-PPARG fusion in a Japanese population.Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer.Immunohistochemical Detection of NRASQ61R Mutation in Diverse Tumor Types.RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1.Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance
P2860
Q26782322-8D5E8353-533A-4DF5-A233-FCF6E6C25B09Q26999887-15B3F52F-97E1-4BD8-8D3B-4E80E84A14ADQ27026163-6185DE76-CCF5-481A-BC8A-8CAAFDC32F68Q27612411-2DA29A62-08C9-4D8F-9B26-09445921B1C0Q33915384-052562B3-A153-4F31-86B5-F00800406AF9Q33931406-8CE53B74-2522-4BDA-8333-A1658720DB66Q34183230-3098FEC2-779C-40F3-A608-F776DA39B480Q34329018-B21E3EC0-3498-4D8F-A3AA-4E9F2B799741Q35042618-72189BA0-53B6-43CD-AEF4-475B7764D3E6Q35057314-4DF181D9-262B-486A-BD22-D94D7C594382Q35858147-995D3CF2-4BFA-4B7A-9C75-7458724C3C7AQ35906046-CF7CA7E1-BA47-4812-86E3-8D9DB628A5F2Q35908104-26DBAAEE-6E84-4A84-A6C2-413D45E7D937Q36096044-90C8D4E5-FC9B-4882-8616-11F4A65F80C3Q36983658-CAE93AE5-5887-4888-9456-36FAF94401F7Q37293524-CA11726C-369E-4C08-9868-EA9866E8DE79Q37486166-11D40CC2-DC6E-43AE-A5E9-A959D692BD2AQ37688417-0A03EA80-86EE-499E-9844-F605D4C84FD0Q38305056-266630AF-50E9-4655-BD68-52A15A3DC51EQ38650146-1F37FD93-FF2C-4997-8436-B938C45586A5Q38823954-BF750592-6F2B-4C89-8702-B64307B35D02Q38883187-B511ABF5-9A01-4065-833A-F0072BD29B9FQ39002659-27FE66C0-AAEE-4A2A-9F99-E7D9203B2A97Q39210671-3191B299-5719-48F7-A0F1-9C69A0EF54AFQ40195630-DCB96DDF-9524-4B46-B2E1-787F927EC671Q40346822-133B284D-3AC3-4C9E-83BB-733E3D7BDC5FQ41180944-452405FA-A7FE-4B6A-AF19-7AADBBEFBBF2Q41288884-05906E6B-84D4-443D-A7D7-1B7269AF2B16Q47646209-DF00C406-E00E-4BCD-9639-C179FEC3F772Q47727611-F6A7AF69-C4FD-4020-B3D0-7ABF3816253FQ52649198-6413D4D3-6B26-4E8C-8146-7EEF9A1FF74CQ53227877-31578159-F4F7-4769-BD50-F6694B099B2AQ53265707-F683BE31-6442-4A14-8B59-A089146829A4Q53439139-F26FEB22-EB19-44EC-88D1-BB8363BFBE0CQ57761907-B3EE61FC-AA77-4836-A225-8FA50BB15A95
P2860
The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The associations between RAS m ...... er and a large patient cohort.
@ast
The associations between RAS m ...... er and a large patient cohort.
@en
The associations between RAS m ...... er and a large patient cohort.
@nl
type
label
The associations between RAS m ...... er and a large patient cohort.
@ast
The associations between RAS m ...... er and a large patient cohort.
@en
The associations between RAS m ...... er and a large patient cohort.
@nl
prefLabel
The associations between RAS m ...... er and a large patient cohort.
@ast
The associations between RAS m ...... er and a large patient cohort.
@en
The associations between RAS m ...... er and a large patient cohort.
@nl
P2093
P3181
P356
P1433
P1476
The associations between RAS m ...... er and a large patient cohort.
@en
P2093
Akira Yoshida
Hiroyuki Hayashi
Michiko Fukahori
Mitsuyo Yoshihara
Munetake Masuda
Naoyuki Okamoto
Shiro Koizume
Shoichi Matsukuma
Tetsuo Kondo
Yohei Miyagi
P3181
P356
10.1089/THY.2011.0261
P577
2012-07-01T00:00:00Z